NuVision Biotherapies
Develops innovative ophthalmic therapies
Total raised
€7.2M
€7,219,243
Funding rounds
3
Investors
8
distinct backers
Active since
2015-06
latest 2026-02
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood21
base rate 30% for Other
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 11y since founding
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-02-06 | Other | €5.5M | Mercia Ventures,Midlands Engine Investment Fund II,Pioneer Group,University of Nottingham | View deal → |
| 2023-03-09 | Other | €1.2M | MEIF Proof of Concept & Early Stage Fund,Mercia’s EIS Funds,Midlands Engine Investment Fund,Pioneer Group,University of Nottingham | View deal → |
| 2015-07-01 | Seed | €456k | Mercia Fund Management | View deal → |
Investors
8Related news
- NuVision Raises Further £1.1M in Fundingfinsmes.com · 2023-03
- techcitynews.com
- finsmes.com